Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Perianal complications of Crohn disease

INTRODUCTION

Crohn disease is a chronic recurrent inflammatory bowel disorder that can affect any gastrointestinal site from the oral cavity to the anus. The major perianal complications include fissures, fistulas, abscesses, and stenosis, alone or in combination, which affect approximately 35 to 45 percent of patients during the course of the disease. Symptoms can vary from anal pain and purulent discharge to bleeding and incontinence, and can be associated with significant morbidity and impaired quality of life [1-3].

The major perianal complications of Crohn disease will be reviewed here. The role of imaging in diagnosing anal abscesses and fistulas and the medical management of Crohn disease are discussed in detail separately. (See "Overview of the medical management of mild to moderate Crohn disease in adults" and "Overview of the medical management of severe or refractory Crohn disease in adults" and "The role of imaging tests in the evaluation of anal abscesses and fistulas" and "Clinical manifestations, diagnosis and prognosis of Crohn disease in adults" and "Immunomodulator therapy in Crohn disease".)

The American Gastroenterological Association (AGA) guidelines for perianal Crohn disease [4], as well as other AGA guidelines, can be accessed through the AGA web site at www.gastro.org/practice/medical-position-statements.

RISK FACTORS

Age, race, and disease location are factors associated with perianal complications in Crohn disease. The role of gender is less certain.

Gender – Conflicting data exist regarding the relationship between gender and the incidence of perianal disease in Crohn disease [5,6]. One report found an increased incidence of fistulas among males [6], while others found no difference [5].

                         

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2014. | This topic last updated: Oct 14, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77:914.
  2. McKee RF, Keenan RA. Perianal Crohn's disease--is it all bad news? Dis Colon Rectum 1996; 39:136.
  3. Platell C, Mackay J, Collopy B, et al. Anal pathology in patients with Crohn's disease. Aust N Z J Surg 1996; 66:5.
  4. American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003; 125:1503.
  5. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn's disease? A population-based study. Clin Gastroenterol Hepatol 2006; 4:1130.
  6. Hellers G, Bergstrand O, Ewerth S, Holmström B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21:525.
  7. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8:244.
  8. Régimbeau JM, Panis Y, Marteau P, et al. Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted? J Am Coll Surg 1999; 189:171.
  9. Lapidus A, Bernell O, Hellers G, Löfberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998; 114:1151.
  10. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology 2006; 130:650.
  11. van Dongen LM, Lubbers EJ. Perianal fistulas in patients with Crohn's disease. Arch Surg 1986; 121:1187.
  12. Pescatori M, Interisano A, Basso L, et al. Management of perianal Crohn's disease. Results of a multicenter study in Italy. Dis Colon Rectum 1995; 38:121.
  13. Nordgren S, Fasth S, Hultén L. Anal fistulas in Crohn's disease: incidence and outcome of surgical treatment. Int J Colorectal Dis 1992; 7:214.
  14. Williams DR, Coller JA, Corman ML, et al. Anal complications in Crohn's disease. Dis Colon Rectum 1981; 24:22.
  15. Buchmann P, Keighley MR, Allan RN, et al. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg 1980; 140:642.
  16. Sweeney JL, Ritchie JK, Nicholls RJ. Anal fissure in Crohn's disease. Br J Surg 1988; 75:56.
  17. Akbar F, Maw A, Bhowmick A. Anal ulceration induced by nicorandil. BMJ 2007; 335:936.
  18. Bonheur JL, Braunstein J, Korelitz BI, Panagopoulos G. Anal skin tags in inflammatory bowel disease: new observations and a clinical review. Inflamm Bowel Dis 2008; 14:1236.
  19. Fleshner PR, Schoetz DJ Jr, Roberts PL, et al. Anal fissure in Crohn's disease: a plea for aggressive management. Dis Colon Rectum 1995; 38:1137.
  20. Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79:357.
  21. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83:383.
  22. Ståhlberg D, Bárány F, Einarsson K, et al. Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole. Scand J Gastroenterol 1991; 26:219.
  23. Farkkila M, Seppala K. Long-term treatment of perianal or fistulous Crohn's disease with ciprofloxacin. Scand J Gastroenterol Suppl 1989; 24:144.
  24. Singh B, George BD, Mortensen NJ. Surgical therapy of perianal Crohn's disease. Dig Liver Dis 2007; 39:988.
  25. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122:875.
  26. Lichtenstein GR, Hanauer SB, Sandborn WJ, Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2009; 104:465.
  27. Haggett PJ, Moore NR, Shearman JD, et al. Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut 1995; 36:407.
  28. Stoker J, Hussain SM, van Kempen D, et al. Endoanal coil in MR imaging of anal fistulas. AJR Am J Roentgenol 1996; 166:360.
  29. Deen KI, Williams JG, Hutchinson R, et al. Fistulas in ano: endoanal ultrasonographic assessment assists decision making for surgery. Gut 1994; 35:391.
  30. Orsoni P, Barthet M, Portier F, et al. Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease. Br J Surg 1999; 86:360.
  31. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121:1064.
  32. Ng SC, Plamondon S, Gupta A, et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Am J Gastroenterol 2009; 104:2973.
  33. Maeda Y, Ng SC, Durdey P, et al. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg 2010; 97:1340.
  34. Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984; 79:533.
  35. Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fistulas in Crohn's disease. Gut 1995; 37:696.
  36. Dejaco C, Harrer M, Waldhoer T, et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18:1113.
  37. Thia KT, Mahadevan U, Feagan BG, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15:17.
  38. Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 1985; 30:58.
  39. Jeshion WC, Larsen KL, Jawad AF, et al. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children. J Clin Gastroenterol 2000; 30:294.
  40. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340:1398.
  41. Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39:374.
  42. Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol 1993; 88:646.
  43. Ierardi E, Principi M, Rendina M, et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. J Clin Gastroenterol 2000; 30:200.
  44. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350:876.
  45. Colombel JF, Schwartz DA, Sandborn WJ, et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009; 58:940.
  46. Sandborn WJ, Present DH, Isaacs KL, et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125:380.
  47. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123:132.
  48. Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther 2003; 18:1003.
  49. Poggioli G, Laureti S, Pierangeli F, et al. Local injection of Infliximab for the treatment of perianal Crohn's disease. Dis Colon Rectum 2005; 48:768.
  50. Hart AL, Plamondon S, Kamm MA. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Inflamm Bowel Dis 2007; 13:245.
  51. Fukuda Y, Takazoe M, Sugita A, et al. Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2008; 103:1721.
  52. Vitton V, Gasmi M, Barthet M, et al. Long-term healing of Crohn's anal fistulas with fibrin glue injection. Aliment Pharmacol Ther 2005; 21:1453.
  53. Loungnarath R, Dietz DW, Mutch MG, et al. Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum 2004; 47:432.
  54. Grimaud JC, Munoz-Bongrand N, Siproudhis L, et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology 2010; 138:2275.
  55. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003; 9:98.
  56. Topstad DR, Panaccione R, Heine JA, et al. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum 2003; 46:577.
  57. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum 2002; 45:771.
  58. Bouguen G, Siproudhis L, Gizard E, et al. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol 2013; 11:975.
  59. Yassin NA, Askari A, Warusavitarne J, et al. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease. Aliment Pharmacol Ther 2014; 40:741.
  60. Morrison JG, Gathright JB Jr, Ray JE, et al. Surgical management of anorectal fistulas in Crohn's disease. Dis Colon Rectum 1989; 32:492.
  61. Scott HJ, Northover JM. Evaluation of surgery for perianal Crohn's fistulas. Dis Colon Rectum 1996; 39:1039.
  62. Thornton M, Solomon MJ. Long-term indwelling seton for complex anal fistulas in Crohn's disease. Dis Colon Rectum 2005; 48:459.
  63. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125:1508.
  64. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005; 128:862.
  65. Michelassi F, Melis M, Rubin M, Hurst RD. Surgical treatment of anorectal complications in Crohn's disease. Surgery 2000; 128:597.
  66. Makowiec F, Jehle EC, Becker HD, Starlinger M. Perianal abscess in Crohn's disease. Dis Colon Rectum 1997; 40:443.
  67. Pritchard TJ, Schoetz DJ Jr, Roberts PL, et al. Perirectal abscess in Crohn's disease. Drainage and outcome. Dis Colon Rectum 1990; 33:933.
  68. Sangwan YP, Schoetz DJ Jr, Murray JJ, et al. Perianal Crohn's disease. Results of local surgical treatment. Dis Colon Rectum 1996; 39:529.
  69. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 1998; 41:992.
  70. Nikias G, Eisner T, Katz S, et al. Crohn's disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Am J Gastroenterol 1995; 90:216.